nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—SMO—glaucoma	0.728	0.832	CbGaD
Fluocinonide—NR3C1—glaucoma	0.147	0.168	CbGaD
Fluocinonide—Skin tightness—Brinzolamide—glaucoma	0.0128	0.108	CcSEcCtD
Fluocinonide—Cataract subcapsular—Dorzolamide—glaucoma	0.00416	0.0351	CcSEcCtD
Fluocinonide—Application site burn—Clonidine—glaucoma	0.00391	0.033	CcSEcCtD
Fluocinonide—Hypertrichosis—Bimatoprost—glaucoma	0.00338	0.0285	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Brimonidine—glaucoma	0.00326	0.0275	CcSEcCtD
Fluocinonide—Eruption—Diclofenamide—glaucoma	0.00302	0.0255	CcSEcCtD
Fluocinonide—Hypertrichosis—Travoprost—glaucoma	0.00285	0.024	CcSEcCtD
Fluocinonide—Glycosuria—Methazolamide—glaucoma	0.00211	0.0178	CcSEcCtD
Fluocinonide—Hypertrichosis—Betaxolol—glaucoma	0.00188	0.0158	CcSEcCtD
Fluocinonide—Application site pain—Clonidine—glaucoma	0.00186	0.0157	CcSEcCtD
Fluocinonide—Glycosuria—Acetazolamide—glaucoma	0.00146	0.0123	CcSEcCtD
Fluocinonide—Nasal congestion—Levobunolol—glaucoma	0.00142	0.012	CcSEcCtD
Fluocinonide—Erythema—Echothiophate—glaucoma	0.00133	0.0112	CcSEcCtD
Fluocinonide—Dermatitis contact—Apraclonidine—glaucoma	0.00131	0.0111	CcSEcCtD
Fluocinonide—Dermatitis contact—Brimonidine—glaucoma	0.00112	0.00949	CcSEcCtD
Fluocinonide—Pain—Dipivefrin—glaucoma	0.00111	0.00935	CcSEcCtD
Fluocinonide—Dermatitis contact—Dorzolamide—glaucoma	0.00107	0.00906	CcSEcCtD
Fluocinonide—Dermatitis contact—Travoprost—glaucoma	0.00107	0.00902	CcSEcCtD
Fluocinonide—Dermatitis contact—Pilocarpine—glaucoma	0.00101	0.00856	CcSEcCtD
Fluocinonide—Hypersensitivity—Dipivefrin—glaucoma	0.000955	0.00806	CcSEcCtD
Fluocinonide—Swelling—Brimonidine—glaucoma	0.000936	0.0079	CcSEcCtD
Fluocinonide—Pain—Echothiophate—glaucoma	0.000929	0.00784	CcSEcCtD
Fluocinonide—Nasal congestion—Brimonidine—glaucoma	0.000907	0.00765	CcSEcCtD
Fluocinonide—Nasal congestion—Dorzolamide—glaucoma	0.000866	0.00731	CcSEcCtD
Fluocinonide—Nasal congestion—Travoprost—glaucoma	0.000862	0.00727	CcSEcCtD
Fluocinonide—Nasopharyngitis—Apraclonidine—glaucoma	0.00086	0.00726	CcSEcCtD
Fluocinonide—Dry skin—Bimatoprost—glaucoma	0.000855	0.00721	CcSEcCtD
Fluocinonide—Nasal congestion—Brinzolamide—glaucoma	0.000851	0.00718	CcSEcCtD
Fluocinonide—Nasopharyngitis—Bimatoprost—glaucoma	0.000834	0.00704	CcSEcCtD
Fluocinonide—Dermatitis contact—Clonidine—glaucoma	0.00081	0.00684	CcSEcCtD
Fluocinonide—Dry skin—Brimonidine—glaucoma	0.000757	0.00639	CcSEcCtD
Fluocinonide—Nasopharyngitis—Brimonidine—glaucoma	0.000739	0.00623	CcSEcCtD
Fluocinonide—Erythema—Latanoprost—glaucoma	0.000725	0.00612	CcSEcCtD
Fluocinonide—Nasopharyngitis—Brinzolamide—glaucoma	0.000693	0.00585	CcSEcCtD
Fluocinonide—Dry skin—Pilocarpine—glaucoma	0.000683	0.00576	CcSEcCtD
Fluocinonide—Nasal congestion—Clonidine—glaucoma	0.000653	0.00551	CcSEcCtD
Fluocinonide—Infection—Carbachol—glaucoma	0.000644	0.00543	CcSEcCtD
Fluocinonide—Hyperglycaemia—Dorzolamide—glaucoma	0.000615	0.00519	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Latanoprost—glaucoma	0.000613	0.00517	CcSEcCtD
Fluocinonide—Nervous system disorder—Latanoprost—glaucoma	0.00058	0.00489	CcSEcCtD
Fluocinonide—Erythema—Apraclonidine—glaucoma	0.000579	0.00489	CcSEcCtD
Fluocinonide—Skin disorder—Latanoprost—glaucoma	0.000575	0.00485	CcSEcCtD
Fluocinonide—Erythema—Bimatoprost—glaucoma	0.000562	0.00474	CcSEcCtD
Fluocinonide—Pain—Carbachol—glaucoma	0.000554	0.00467	CcSEcCtD
Fluocinonide—Pain—Levobunolol—glaucoma	0.000545	0.0046	CcSEcCtD
Fluocinonide—Hypersensitivity—Metipranolol—glaucoma	0.000537	0.00453	CcSEcCtD
Fluocinonide—Nasopharyngitis—Clonidine—glaucoma	0.000532	0.00449	CcSEcCtD
Fluocinonide—Immune system disorder—Brimonidine—glaucoma	0.000516	0.00435	CcSEcCtD
Fluocinonide—Pain—Latanoprost—glaucoma	0.000506	0.00427	CcSEcCtD
Fluocinonide—Erythema—Brimonidine—glaucoma	0.000497	0.0042	CcSEcCtD
Fluocinonide—Hypersensitivity—Carteolol—glaucoma	0.000497	0.0042	CcSEcCtD
Fluocinonide—Immune system disorder—Travoprost—glaucoma	0.000491	0.00414	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.00049	0.00413	CcSEcCtD
Fluocinonide—Immune system disorder—Brinzolamide—glaucoma	0.000485	0.00409	CcSEcCtD
Fluocinonide—Dizziness—Metipranolol—glaucoma	0.000482	0.00407	CcSEcCtD
Fluocinonide—Erythema—Dorzolamide—glaucoma	0.000475	0.00401	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000475	0.00401	CcSEcCtD
Fluocinonide—Erythema—Travoprost—glaucoma	0.000473	0.00399	CcSEcCtD
Fluocinonide—Hypersensitivity—Levobunolol—glaucoma	0.00047	0.00397	CcSEcCtD
Fluocinonide—Infection—Apraclonidine—glaucoma	0.00047	0.00396	CcSEcCtD
Fluocinonide—Pruritus—Diclofenamide—glaucoma	0.00047	0.00396	CcSEcCtD
Fluocinonide—Erythema—Brinzolamide—glaucoma	0.000467	0.00394	CcSEcCtD
Fluocinonide—Nasal congestion—Timolol—glaucoma	0.000465	0.00392	CcSEcCtD
Fluocinonide—Nervous system disorder—Apraclonidine—glaucoma	0.000464	0.00391	CcSEcCtD
Fluocinonide—Nasopharyngitis—Betaxolol—glaucoma	0.000463	0.00391	CcSEcCtD
Fluocinonide—Rash—Metipranolol—glaucoma	0.000459	0.00388	CcSEcCtD
Fluocinonide—Skin disorder—Apraclonidine—glaucoma	0.000459	0.00388	CcSEcCtD
Fluocinonide—Dermatitis—Metipranolol—glaucoma	0.000459	0.00387	CcSEcCtD
Fluocinonide—Headache—Metipranolol—glaucoma	0.000456	0.00385	CcSEcCtD
Fluocinonide—Infection—Bimatoprost—glaucoma	0.000455	0.00384	CcSEcCtD
Fluocinonide—Pruritus—Levobunolol—glaucoma	0.000451	0.00381	CcSEcCtD
Fluocinonide—Nervous system disorder—Bimatoprost—glaucoma	0.00045	0.00379	CcSEcCtD
Fluocinonide—Dizziness—Carteolol—glaucoma	0.000446	0.00377	CcSEcCtD
Fluocinonide—Skin disorder—Bimatoprost—glaucoma	0.000445	0.00376	CcSEcCtD
Fluocinonide—Dizziness—Diclofenamide—glaucoma	0.000439	0.0037	CcSEcCtD
Fluocinonide—Dizziness—Carbachol—glaucoma	0.000428	0.00361	CcSEcCtD
Fluocinonide—Headache—Carteolol—glaucoma	0.000423	0.00357	CcSEcCtD
Fluocinonide—Dizziness—Levobunolol—glaucoma	0.000422	0.00356	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000421	0.00355	CcSEcCtD
Fluocinonide—Pruritus—Latanoprost—glaucoma	0.000418	0.00353	CcSEcCtD
Fluocinonide—Rash—Diclofenamide—glaucoma	0.000418	0.00353	CcSEcCtD
Fluocinonide—Headache—Diclofenamide—glaucoma	0.000416	0.00351	CcSEcCtD
Fluocinonide—Rash—Carbachol—glaucoma	0.000408	0.00345	CcSEcCtD
Fluocinonide—Dermatitis—Carbachol—glaucoma	0.000408	0.00344	CcSEcCtD
Fluocinonide—Headache—Carbachol—glaucoma	0.000406	0.00342	CcSEcCtD
Fluocinonide—Pain—Apraclonidine—glaucoma	0.000404	0.00341	CcSEcCtD
Fluocinonide—Hyperglycaemia—Betaxolol—glaucoma	0.000404	0.00341	CcSEcCtD
Fluocinonide—Infection—Brimonidine—glaucoma	0.000403	0.0034	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.0004	0.00337	CcSEcCtD
Fluocinonide—Headache—Levobunolol—glaucoma	0.0004	0.00337	CcSEcCtD
Fluocinonide—Nervous system disorder—Brimonidine—glaucoma	0.000398	0.00336	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000395	0.00333	CcSEcCtD
Fluocinonide—Skin disorder—Brimonidine—glaucoma	0.000394	0.00333	CcSEcCtD
Fluocinonide—Pain—Bimatoprost—glaucoma	0.000392	0.00331	CcSEcCtD
Fluocinonide—Dizziness—Latanoprost—glaucoma	0.000391	0.0033	CcSEcCtD
Fluocinonide—Rash—Methazolamide—glaucoma	0.000385	0.00325	CcSEcCtD
Fluocinonide—Dermatitis—Methazolamide—glaucoma	0.000385	0.00325	CcSEcCtD
Fluocinonide—Infection—Travoprost—glaucoma	0.000384	0.00324	CcSEcCtD
Fluocinonide—Headache—Methazolamide—glaucoma	0.000383	0.00323	CcSEcCtD
Fluocinonide—Infection—Brinzolamide—glaucoma	0.000379	0.0032	CcSEcCtD
Fluocinonide—Nervous system disorder—Travoprost—glaucoma	0.000379	0.00319	CcSEcCtD
Fluocinonide—Nasopharyngitis—Timolol—glaucoma	0.000379	0.00319	CcSEcCtD
Fluocinonide—Skin disorder—Travoprost—glaucoma	0.000375	0.00316	CcSEcCtD
Fluocinonide—Nervous system disorder—Brinzolamide—glaucoma	0.000374	0.00315	CcSEcCtD
Fluocinonide—Rash—Latanoprost—glaucoma	0.000373	0.00315	CcSEcCtD
Fluocinonide—Dermatitis—Latanoprost—glaucoma	0.000373	0.00314	CcSEcCtD
Fluocinonide—Headache—Latanoprost—glaucoma	0.000371	0.00313	CcSEcCtD
Fluocinonide—Skin disorder—Brinzolamide—glaucoma	0.00037	0.00312	CcSEcCtD
Fluocinonide—Infection—Pilocarpine—glaucoma	0.000364	0.00307	CcSEcCtD
Fluocinonide—Erythema—Clonidine—glaucoma	0.000358	0.00302	CcSEcCtD
Fluocinonide—Hypersensitivity—Apraclonidine—glaucoma	0.000348	0.00294	CcSEcCtD
Fluocinonide—Pain—Brimonidine—glaucoma	0.000347	0.00293	CcSEcCtD
Fluocinonide—Pruritus—Apraclonidine—glaucoma	0.000335	0.00282	CcSEcCtD
Fluocinonide—Pain—Dorzolamide—glaucoma	0.000332	0.0028	CcSEcCtD
Fluocinonide—Pain—Travoprost—glaucoma	0.00033	0.00279	CcSEcCtD
Fluocinonide—Hyperglycaemia—Timolol—glaucoma	0.00033	0.00278	CcSEcCtD
Fluocinonide—Pain—Brinzolamide—glaucoma	0.000326	0.00275	CcSEcCtD
Fluocinonide—Pruritus—Bimatoprost—glaucoma	0.000324	0.00274	CcSEcCtD
Fluocinonide—Immune system disorder—Betaxolol—glaucoma	0.000324	0.00273	CcSEcCtD
Fluocinonide—Difluprednate—NR3C1—glaucoma	0.000323	0.0568	CrCbGaD
Fluocinonide—Pain—Pilocarpine—glaucoma	0.000313	0.00264	CcSEcCtD
Fluocinonide—Clocortolone—NR3C1—glaucoma	0.000313	0.0551	CrCbGaD
Fluocinonide—Dizziness—Apraclonidine—glaucoma	0.000313	0.00264	CcSEcCtD
Fluocinonide—Erythema—Betaxolol—glaucoma	0.000312	0.00263	CcSEcCtD
Fluocinonide—Dizziness—Bimatoprost—glaucoma	0.000303	0.00256	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000303	0.00256	CcSEcCtD
Fluocinonide—Hypersensitivity—Brimonidine—glaucoma	0.000299	0.00252	CcSEcCtD
Fluocinonide—Dermatitis—Apraclonidine—glaucoma	0.000298	0.00251	CcSEcCtD
Fluocinonide—Headache—Apraclonidine—glaucoma	0.000296	0.0025	CcSEcCtD
Fluocinonide—Desonide—NR3C1—glaucoma	0.000296	0.0522	CrCbGaD
Fluocinonide—Diflorasone—NR3C1—glaucoma	0.000296	0.0522	CrCbGaD
Fluocinonide—Infection—Clonidine—glaucoma	0.000291	0.00245	CcSEcCtD
Fluocinonide—Rash—Bimatoprost—glaucoma	0.000289	0.00244	CcSEcCtD
Fluocinonide—Desoximetasone—NR3C1—glaucoma	0.000289	0.0509	CrCbGaD
Fluocinonide—Dermatitis—Bimatoprost—glaucoma	0.000289	0.00244	CcSEcCtD
Fluocinonide—Pruritus—Brimonidine—glaucoma	0.000287	0.00242	CcSEcCtD
Fluocinonide—Headache—Bimatoprost—glaucoma	0.000287	0.00242	CcSEcCtD
Fluocinonide—Nervous system disorder—Clonidine—glaucoma	0.000287	0.00242	CcSEcCtD
Fluocinonide—Hypersensitivity—Dorzolamide—glaucoma	0.000286	0.00241	CcSEcCtD
Fluocinonide—Hypersensitivity—Travoprost—glaucoma	0.000284	0.0024	CcSEcCtD
Fluocinonide—Skin disorder—Clonidine—glaucoma	0.000284	0.0024	CcSEcCtD
Fluocinonide—Hypersensitivity—Brinzolamide—glaucoma	0.000281	0.00237	CcSEcCtD
Fluocinonide—Dizziness—Acetazolamide—glaucoma	0.00028	0.00236	CcSEcCtD
Fluocinonide—Pruritus—Dorzolamide—glaucoma	0.000274	0.00231	CcSEcCtD
Fluocinonide—Pruritus—Travoprost—glaucoma	0.000273	0.0023	CcSEcCtD
Fluocinonide—Hypersensitivity—Pilocarpine—glaucoma	0.00027	0.00228	CcSEcCtD
Fluocinonide—Pruritus—Brinzolamide—glaucoma	0.00027	0.00228	CcSEcCtD
Fluocinonide—Dizziness—Brimonidine—glaucoma	0.000268	0.00227	CcSEcCtD
Fluocinonide—Headache—Acetazolamide—glaucoma	0.000265	0.00224	CcSEcCtD
Fluocinonide—Immune system disorder—Timolol—glaucoma	0.000265	0.00223	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000264	0.00223	CcSEcCtD
Fluocinonide—Pruritus—Pilocarpine—glaucoma	0.000259	0.00219	CcSEcCtD
Fluocinonide—Dizziness—Dorzolamide—glaucoma	0.000256	0.00216	CcSEcCtD
Fluocinonide—Rash—Brimonidine—glaucoma	0.000256	0.00216	CcSEcCtD
Fluocinonide—Dermatitis—Brimonidine—glaucoma	0.000256	0.00216	CcSEcCtD
Fluocinonide—Dizziness—Travoprost—glaucoma	0.000255	0.00215	CcSEcCtD
Fluocinonide—Erythema—Timolol—glaucoma	0.000255	0.00215	CcSEcCtD
Fluocinonide—Headache—Brimonidine—glaucoma	0.000254	0.00215	CcSEcCtD
Fluocinonide—Infection—Betaxolol—glaucoma	0.000253	0.00214	CcSEcCtD
Fluocinonide—Flurandrenolide—NR3C1—glaucoma	0.000253	0.0445	CrCbGaD
Fluocinonide—Dizziness—Brinzolamide—glaucoma	0.000252	0.00213	CcSEcCtD
Fluocinonide—Pain—Clonidine—glaucoma	0.00025	0.00211	CcSEcCtD
Fluocinonide—Nervous system disorder—Betaxolol—glaucoma	0.00025	0.00211	CcSEcCtD
Fluocinonide—Flumethasone Pivalate—NR3C1—glaucoma	0.000249	0.0438	CrCbGaD
Fluocinonide—Skin disorder—Betaxolol—glaucoma	0.000247	0.00209	CcSEcCtD
Fluocinonide—Halobetasol Propionate—NR3C1—glaucoma	0.000245	0.0431	CrCbGaD
Fluocinonide—Rash—Dorzolamide—glaucoma	0.000244	0.00206	CcSEcCtD
Fluocinonide—Dermatitis—Dorzolamide—glaucoma	0.000244	0.00206	CcSEcCtD
Fluocinonide—Rash—Travoprost—glaucoma	0.000243	0.00205	CcSEcCtD
Fluocinonide—Dermatitis—Travoprost—glaucoma	0.000243	0.00205	CcSEcCtD
Fluocinonide—Headache—Dorzolamide—glaucoma	0.000243	0.00205	CcSEcCtD
Fluocinonide—Dizziness—Pilocarpine—glaucoma	0.000242	0.00204	CcSEcCtD
Fluocinonide—Headache—Travoprost—glaucoma	0.000242	0.00204	CcSEcCtD
Fluocinonide—Rash—Brinzolamide—glaucoma	0.00024	0.00203	CcSEcCtD
Fluocinonide—Dermatitis—Brinzolamide—glaucoma	0.00024	0.00203	CcSEcCtD
Fluocinonide—Headache—Brinzolamide—glaucoma	0.000239	0.00201	CcSEcCtD
Fluocinonide—Rash—Pilocarpine—glaucoma	0.000231	0.00195	CcSEcCtD
Fluocinonide—Dermatitis—Pilocarpine—glaucoma	0.000231	0.00195	CcSEcCtD
Fluocinonide—Headache—Pilocarpine—glaucoma	0.00023	0.00194	CcSEcCtD
Fluocinonide—Amcinonide—NR3C1—glaucoma	0.000227	0.04	CrCbGaD
Fluocinonide—Budesonide—NR3C1—glaucoma	0.000227	0.04	CrCbGaD
Fluocinonide—Fluticasone furoate—NR3C1—glaucoma	0.000223	0.0393	CrCbGaD
Fluocinonide—Pain—Betaxolol—glaucoma	0.000218	0.00184	CcSEcCtD
Fluocinonide—Mometasone—NR3C1—glaucoma	0.000216	0.0381	CrCbGaD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000216	0.00182	CcSEcCtD
Fluocinonide—Hypersensitivity—Clonidine—glaucoma	0.000216	0.00182	CcSEcCtD
Fluocinonide—Rimexolone—NR3C1—glaucoma	0.000214	0.0377	CrCbGaD
Fluocinonide—Pruritus—Clonidine—glaucoma	0.000207	0.00175	CcSEcCtD
Fluocinonide—Infection—Timolol—glaucoma	0.000207	0.00174	CcSEcCtD
Fluocinonide—Nervous system disorder—Timolol—glaucoma	0.000204	0.00172	CcSEcCtD
Fluocinonide—Skin disorder—Timolol—glaucoma	0.000202	0.00171	CcSEcCtD
Fluocinonide—Beclomethasone—NR3C1—glaucoma	0.000202	0.0355	CrCbGaD
Fluocinonide—Fluocinolone Acetonide—NR3C1—glaucoma	0.000196	0.0345	CrCbGaD
Fluocinonide—Dizziness—Clonidine—glaucoma	0.000193	0.00163	CcSEcCtD
Fluocinonide—Clobetasol propionate—NR3C1—glaucoma	0.000191	0.0336	CrCbGaD
Fluocinonide—Flunisolide—NR3C1—glaucoma	0.000191	0.0336	CrCbGaD
Fluocinonide—Paramethasone—NR3C1—glaucoma	0.000188	0.0332	CrCbGaD
Fluocinonide—Hypersensitivity—Betaxolol—glaucoma	0.000188	0.00158	CcSEcCtD
Fluocinonide—Ciclesonide—NR3C1—glaucoma	0.000185	0.0326	CrCbGaD
Fluocinonide—Rash—Clonidine—glaucoma	0.000184	0.00156	CcSEcCtD
Fluocinonide—Dermatitis—Clonidine—glaucoma	0.000184	0.00155	CcSEcCtD
Fluocinonide—Fluorometholone—NR3C1—glaucoma	0.000184	0.0324	CrCbGaD
Fluocinonide—Headache—Clonidine—glaucoma	0.000183	0.00155	CcSEcCtD
Fluocinonide—Pruritus—Betaxolol—glaucoma	0.00018	0.00152	CcSEcCtD
Fluocinonide—Pain—Timolol—glaucoma	0.000178	0.0015	CcSEcCtD
Fluocinonide—Methylprednisolone—NR3C1—glaucoma	0.000178	0.0313	CrCbGaD
Fluocinonide—Dizziness—Betaxolol—glaucoma	0.000168	0.00142	CcSEcCtD
Fluocinonide—Rash—Betaxolol—glaucoma	0.000161	0.00136	CcSEcCtD
Fluocinonide—Dermatitis—Betaxolol—glaucoma	0.00016	0.00135	CcSEcCtD
Fluocinonide—Headache—Betaxolol—glaucoma	0.00016	0.00135	CcSEcCtD
Fluocinonide—Hypersensitivity—Timolol—glaucoma	0.000153	0.00129	CcSEcCtD
Fluocinonide—Triamcinolone—NR3C1—glaucoma	0.00015	0.0264	CrCbGaD
Fluocinonide—Pruritus—Timolol—glaucoma	0.000147	0.00124	CcSEcCtD
Fluocinonide—Dizziness—Timolol—glaucoma	0.000138	0.00116	CcSEcCtD
Fluocinonide—Fluticasone Propionate—NR3C1—glaucoma	0.000134	0.0236	CrCbGaD
Fluocinonide—Rash—Timolol—glaucoma	0.000131	0.00111	CcSEcCtD
Fluocinonide—Dermatitis—Timolol—glaucoma	0.000131	0.00111	CcSEcCtD
Fluocinonide—SMO—Signaling events mediated by the Hedgehog family—TGFB2—glaucoma	0.000131	0.167	CbGpPWpGaD
Fluocinonide—Headache—Timolol—glaucoma	0.00013	0.0011	CcSEcCtD
Fluocinonide—Betamethasone—NR3C1—glaucoma	0.000123	0.0216	CrCbGaD
Fluocinonide—Dexamethasone—CYP1B1—glaucoma	0.00012	0.0212	CrCbGaD
Fluocinonide—SMO—GPCRs, Other—PTGFR—glaucoma	8.99e-05	0.115	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	8.93e-05	0.114	CbGpPWpGaD
Fluocinonide—Triamcinolone—PTGS2—glaucoma	8.51e-05	0.015	CrCbGaD
Fluocinonide—Dexamethasone—NR3C1—glaucoma	7.14e-05	0.0126	CrCbGaD
Fluocinonide—Betamethasone—PTGS2—glaucoma	6.97e-05	0.0123	CrCbGaD
Fluocinonide—Dexamethasone—PTGS2—glaucoma	4.05e-05	0.00714	CrCbGaD
Fluocinonide—NR3C1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	2.94e-05	0.0376	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—OPN4—glaucoma	2.83e-05	0.0362	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—LMX1B—glaucoma	2.65e-05	0.0339	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—PTGFR—glaucoma	2.55e-05	0.0325	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1.87e-05	0.0239	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.72e-05	0.022	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.71e-05	0.0218	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.46e-05	0.0187	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OPN4—glaucoma	1.45e-05	0.0186	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PTGFR—glaucoma	1.31e-05	0.0167	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	1.25e-05	0.016	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—LRP12—glaucoma	1.24e-05	0.0158	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HDAC9—glaucoma	9.51e-06	0.0121	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—EDN1—glaucoma	9.31e-06	0.0119	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	9.2e-06	0.0118	CbGpPWpGaD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—glaucoma	8.84e-06	0.0113	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	8.71e-06	0.0111	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	8.63e-06	0.011	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OPN4—glaucoma	8.58e-06	0.011	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—EDN1—glaucoma	8.47e-06	0.0108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HEYL—glaucoma	7.97e-06	0.0102	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP1—glaucoma	7.83e-06	0.01	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTGFR—glaucoma	7.72e-06	0.00987	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—C3—glaucoma	7.4e-06	0.00945	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	7.25e-06	0.00926	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—glaucoma	6.9e-06	0.00881	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NTRK2—glaucoma	6.8e-06	0.00869	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	6.21e-06	0.00794	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RPTOR—glaucoma	6.04e-06	0.00772	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NCK2—glaucoma	5.85e-06	0.00748	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN2A—glaucoma	5.55e-06	0.00709	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	5.48e-06	0.007	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—glaucoma	5.08e-06	0.00649	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—FAS—glaucoma	5.03e-06	0.00643	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HDAC9—glaucoma	4.98e-06	0.00636	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CDKN1B—glaucoma	4.91e-06	0.00628	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1A—glaucoma	4.88e-06	0.00623	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—glaucoma	4.55e-06	0.00582	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—NGF—glaucoma	4.51e-06	0.00576	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—EDN1—glaucoma	4.35e-06	0.00555	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—C3—glaucoma	3.8e-06	0.00485	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK2—glaucoma	3.56e-06	0.00455	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TP53—glaucoma	3.09e-06	0.00395	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGFR—glaucoma	3.06e-06	0.0039	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NTRK1—glaucoma	2.9e-06	0.00371	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—glaucoma	2.72e-06	0.00348	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN2B—glaucoma	2.68e-06	0.00342	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EDN1—glaucoma	2.57e-06	0.00328	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NGF—glaucoma	2.36e-06	0.00301	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—C3—glaucoma	2.24e-06	0.00287	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—CDKN2B—glaucoma	2.16e-06	0.00276	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—glaucoma	2.15e-06	0.00275	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—glaucoma	2.13e-06	0.00273	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—glaucoma	2.09e-06	0.00267	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CAV1—glaucoma	2.07e-06	0.00264	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—FN1—glaucoma	1.97e-06	0.00252	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—BAD—glaucoma	1.95e-06	0.00249	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—glaucoma	1.85e-06	0.00236	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NOS3—glaucoma	1.56e-06	0.002	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CDKN1B—glaucoma	1.36e-06	0.00173	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—glaucoma	1.26e-06	0.0016	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—VEGFA—glaucoma	1.13e-06	0.00144	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CDKN2B—glaucoma	1.04e-06	0.00133	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TP53—glaucoma	8.52e-07	0.00109	CbGpPWpGaD
